Finding more active antioxidants and cancer chemoprevention agents by elongating the conjugated links of resveratrol

Free Radical Biology and Medicine

Volumn 50, Issue 10, 2011, Pages 1447-1457

  Tang, Jiang Jiang ^a   Fan, Gui Juan ^a   Dai, Fang ^a   Ding, De Jun ^a   Wang, Qi ^a   Lu, Dong Liang ^a   Li, Ran Ran ^a   Li, Xiu Zhuang ^a   Hu, Li Mei ^a   Jin, Xiao Ling ^a   Zhou, Bo ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

Analogs; Antioxidant; Cancer chemoprevention; Free radicals; Resveratrol; Stilbenoid

Indexed keywords

4,4' DIHYDROXYBIPHENYLHEXATRIENE; ANTINEOPLASTIC AGENT; ANTIOXIDANT; APOPTOSIS INDUCING FACTOR; HYDROGEN; RESVERATROL; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; ATOM; CHEMOPROPHYLAXIS; CONTROLLED STUDY; CYTOTOXICITY; ELECTRON; ELECTRON TRANSPORT; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; APOPTOSIS; CELL CYCLE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; HL-60 CELLS; HUMANS; MOLECULAR STRUCTURE; STEREOISOMERISM; STILBENES; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 79955465574     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2011.02.028     Document Type: Article

References (84)

1. N.P. Gullett, A.R.M. Ruhul Amin, S. Bayraktar, J.M. Pezzuto, D.M. Shin, F.R. Khuri, B.B. Aggarwal, Y.-J. Surh, and O. Kucuk Cancer prevention with natural compounds Semin. Oncol. 37 2010 258 281
2. N. Khan, F. Afaq, and H. Mukhtar Cancer chemoprevention through dietary antioxidants: progress and promise Antioxid. Redox Signaling 10 2008 475 510
3. M.-H. Pan, and C.-T. Ho Chemopreventive effects of natural dietary compounds on cancer development Chem. Soc. Rev. 37 2008 2558 2574
4. S. Ramos Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways Mol. Nutr. Food Res. 52 2008 507 526
5. J. Francy-Guilford, and J.M. Pezzuto Mechanisms of cancer chemopreventive agents: a perspective Planta Med. 74 2008 1644 1650
6. B.B. Aggarwal, and S. Shishodia Molecular targets of dietary agents for prevention and therapy of cancer Biochem. Pharmacol. 71 2006 1397 1421
7. Y.-J. Surh Cancer chemoprevention with dietary phytochemicals Nat. Rev. Cancer 3 2003 768 780 (Pubitemid 37328815)
8. M. Athar, J.H. Back, L. Kopelovich, D.R. Bickers, and A.L. Kim Multiple molecular targets of resveratrol: anti-carcinogenic mechanisms Arch. Biochem. Biophys. 486 2009 95 102
9. M. Shakibaei, K.B. Harikumar, and B.B. Aggarwal Resveratrol addiction: to die or not to die Mol. Nutr. Food Res. 53 2009 115 128
10. S. Pervaiz, and A.L. Holme Resveratrol: its biologic targets and functional activity Antioxid. Redox Signaling 11 2009 2851 2857
11. P. Saiko, A. Szakmary, W. Jaeger, and T. Szekeres Resveratrol and its analogs: defense against cancer, coronary disease and neurodegenerative maladies or just a fad? Mutat. Res. 658 2008 68 94 (Pubitemid 351172881)
12. J.M. Pezzuto Grapes and human health: a perspective J. Agric. Food Chem. 56 2008 6777 6784
13. J.K. Kundu, and Y.-J. Surh Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives Cancer Lett. 269 2008 243 261
14. J.A. Baur, and D.A. Sinclair Therapeutic potential of resveratrol: the in vivo evidence Nat. Rev. Drug Discovery 5 2006 493 506 (Pubitemid 44136961)
15. P. Signorelli, and R. Ghidoni Resveratrol as an anticancer nutrient: molecular basis, open questions and promises J. Nutr. Biochem. 16 2005 449 466 (Pubitemid 41039220)
16. S. Ulrich, F. Wolter, and J.M. Stein Molecular mechanisms of the chemopreventive effects of resveratrol and its analogs in carcinogenesis Mol. Nutr. Food Res. 49 2005 452 461 (Pubitemid 40780392)
17. D. Delmas, A. Lancon, D. Colin, B. Jannin, and N. Latruffe Resveratrol as a chemopreventive agent: a promising molecule for fighting cancer Curr. Drug Targets 7 2006 423 442 (Pubitemid 43744833)
18. B.B. Aggarwal, A. Bhardwaj, R.S. Aggarwal, N.P. Seeram, S. Shishodia, and Y. Takada Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies Anticancer Res. 24 2004 2783 2840 (Pubitemid 39409568)
19. M. Jang, L. Cai, G.O. Udeani, K.V. Slowing, C.F. Thomas, C.W. Beecher, H.H.S. Fong, N.R. Farnsworth, A.D. Kinghorn, R.G. Mehta, R.C. Moon, and J.M. Pezzuto Cancer chemopreventive activity of resveratrol, a natural product derived from grapes Science 275 1997 218 220 (Pubitemid 127696281)
20. S.K. Lee, W. Zhang, and B.J.S. Sanderson Selective growth inhibition of human leukemia and human lymphoblastoid cells by resveratrol via cell cycle arrest and apoptosis induction J. Agric. Food Chem. 56 2008 7572 7577
21. J. Dörrie, H. Gerauer, Y. Wachter, and S.J. Zunino Resveratrol induces extensive apoptosis by depolarizing mitochondrial membranes and activating caspase-9 in acute lymphoblastic leukemia cells Cancer Res. 61 2001 4731 4739 (Pubitemid 32691883)
22. M.-V. Clément, J.L. Hirpara, S.H. Chawdhury, and S. Pervaiz Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells Blood 92 1998 996 1002 (Pubitemid 28355484)
23. E. Wenzel, and V. Somoza Metabolism and bioavailability of trans-resveratrol Mol. Nutr. Food Res. 49 2005 472 481 (Pubitemid 40780394)
24. D.M. Goldberg, J. Yan, and G.J. Soleas Absorption of three wine-related polyphenols in three different matrices by healthy subjects Clin. Biochem. 36 2003 79 87 (Pubitemid 36126394)
25. S.H. Jeong, W.S. Jo, S. Song, H. Suh, S.-Y. Seol, S.-H. Leem, T.K. Kwon, and Y.H. Yoo A novel resveratrol derivative, HS1793, overcomes the resistance conferred by Bcl-2 in human leukemic U937 cells Biochem. Pharmacol. 77 2009 1337 1347
26. S. Fulda Resveratrol and derivatives for the prevention and treatment of cancer Drug Discov. Today 15 2010 757 765 and references therein
27. M.-H. Pan, C.-L. Lin, J.-H. Tsai, C.-T. Ho, and W.-J. Chen 3,5,3′,4′,5′-Pentamethoxystilbene (MR-5), a synthetically methoxylated analogue of resveratrol, inhibits growth and induces G1 cell cycle arrest of human breast carcinoma MCF-7 cells J. Agric. Food Chem. 58 2010 226 234
28. S. Madlener, P. Saiko, C. Vonach, K. Viola, N. Huttary, N. Stark, R. Popescu, M. Gridling, N.T.-P. Vo, I. Herbacek, A. Davidovits, B. Giessrigl, S. Venkateswarlu, S. Geleff, W. Jäger, M. Grusch, D. Kerjaschki, W. Mikulits, T. Golakoti, M. Fritzer-Szekeres, T. Szekeres, and G. Krupitza Multifactorial anticancer effects of digalloyl-resveratrol encompass apoptosis, cell-cycle arrest, and inhibition of lymphendothelial gap formation in vitro Br. J. Cancer 102 2010 1361 1370
29. M. Savio, T. Coppa, L. Bianchi, V. Vannini, G. Maga, L. Forti, O. Cazzalini, M.C. Lazzè, P. Perucca, E. Prosperi, and L.A. Stivala The resveratrol analogue 4,4′-dihydroxy-trans-stilbene inhibits cell proliferation with higher efficiency but different mechanism from resveratrol Int. J. Biochem. Cell Biol. 41 2009 2493 2502
30. G.R. Pettit, N. Melody, A. Thornhill, J.C. Knight, T.L. Groy, and C.L. Herald Antineoplastic agents. 579. Synthesis and cancer cell growth evaluation of E-stilstatin 3: a resveratrol structural modification J. Nat. Prod. 72 2009 1637 1642
31. M. Murias, M.W. Luczak, A. Niepsuj, V. Krajka-Kuzniak, M. Zielinska-Przyjemska, P.P. Jagodzinski, W. Jäger, T. Szekeres, and J. Jodynis-Liebert Cytotoxic activity of 3,3′,4,4′,5,5′- hexahydroxystilbene against breast cancer cells is mediated by induction of p53 and downregulation of mitochondrial superoxide dismutase Toxicol. In Vitro 22 2008 1361 1370
32. K.V. Balan, Y. Wang, S.W. Chen, J.-C. Chen, L.-F. Zheng, L. Yang, Z.-L. Liu, P. Pantazis, J.-H. Wyche, and Z. Han Proteasome-independent down-regulation of estrogen receptor-α (ERα) in breast cancer cells treated with 4,4′-dihydroxy-trans-stilbene Biochem. Pharmacol. 72 2006 573 581 (Pubitemid 44163306)
33. M. Roberti, D. Pizzirani, M. Recanatini, D. Simoni, S. Grimaudo, A.D. Cristina, V. Abbadessa, N. Gebbia, and M. Tolomeo Identification of a terphenyl derivative that blocks the cell cycle in the G0-G1 phase and induces differentiation in leukemia cells J. Med. Chem. 49 2006 3012 3018
34. A. Gosslau, M. Chen, C.T. Ho, and K.Y. Chen A methoxy derivative of resveratrol analogue selectively induced activation of the mitochondrial apoptotic pathway in transformed fibroblasts Br. J. Cancer 92 2005 513 521 (Pubitemid 40395532)
35. Y. Wang, B. Wang, J. Cheng, L. Yang, Z.-L. Liu, K. Balan, P. Pantazis, J.H. Wyche, and Z. Han FADD-dependent apoptosis induction in Jurkat leukemia T-cells by the resveratrol analogue, 3,4,5-trihydroxy-trans-stilbene Biochem. Pharmacol. 69 2005 249 254 (Pubitemid 41556571)
36. C.J. Lion, C.S. Matthews, M.F.G. Stevens, and A.D. Westwell Synthesis, antitumor evaluation, and apoptosis-inducing activity of hydroxylated (E)-stilbenes J. Med. Chem. 48 2005 1292 1295 (Pubitemid 40270477)
37. S. Sale, R.D. Verschoyle, D. Boocock, D.J.L. Jones, N. Wilsher, K.C. Ruparelia, G.A. Potter, P.B. Farmer, W.P. Steward, and A.J. Gescher Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4′-tetramethoxystilbene Br. J. Cancer 90 2004 736 744 (Pubitemid 38297218)
38. M. Roberti, D. Pizzirani, D. Simoni, R. Rondanin, R. Baruchello, C. Bonora, F. Buscemi, S. Grimaudo, and M. Tolomeo Synthesis and biological evaluation of resveratrol and analogues as apoptosis-inducing agents J. Med. Chem. 46 2003 3546 3554 (Pubitemid 36909831)
39. J. Lu, C.-T. Ho, G. Ghai, and K.Y. Chen Resveratrol analog, 3,4,5,4′-tetrahydroxystilbene, differentially induces pro-apoptotic p53/Bax gene expression and inhibits the growth of transformed cells but not their normal counterparts Carcinogenesis 22 2001 321 328 (Pubitemid 32175522)
40. J.E. Klaunig, and L.M. Kamendulis The role of oxidative stress in carcinogenesis Annu. Rev. Pharmacol. Toxicol. 44 2004 239 267 (Pubitemid 38263841)
41. S.P. Hussain, L.J. Hofseth, and C.C. Harris Radical causes of cancer Nat. Rev. Cancer 3 2003 276 285 (Pubitemid 37328863)
42. A.N. Queiroz, B.A.Q. Gomes, J.W.M. Moraes, and R.S. Borges A theoretical antioxidant pharmacophore for resveratrol Eur. J. Med. Chem. 44 2009 1644 1649
43. K. Fukuhara, I. Nakanishi, A. Matsuoka, T. Matsumura, S. Honda, M. Hayashi, T. Ozawa, N. Miyata, S. Saito, N. Ikota, and H. Okuda Effect of methyl substitution on the antioxidative property and genotoxicity of resveratrol Chem. Res. Toxicol. 21 2008 282 287
44. S. Fabris, F. Momo, G. Ravagnan, and R. Stevanato Antioxidant properties of resveratrol and piceid on lipid peroxidation in micelles and monolamellar liposomes Biophys. Chem. 135 2008 76 83
45. M. Murias, W. Jäger, N. Handler, T. Erker, Z. Horvath, T. Szekeres, H. Nohl, and L. Gille Antioxidant, prooxidant and cytotoxic activity of hydroxylated resveratrol analogues: structure-activity relationship Biochem. Pharmacol. 69 2005 903 912 (Pubitemid 40312708)
46. R. Amorati, M. Lucarini, V. Mugnaini, G.F. Pedulli, M. Roberti, and D. Pizzirani Antioxidant activity of hydroxystilbene derivatives in homogeneous solution J. Org. Chem. 69 2004 7101 7107 (Pubitemid 39363006)
47. F. Caruso, J. Tanski, A. Villegas-Estrada, and M. Rossi Structural basis for antioxidant activity of trans-resveratrol: ab initio calculations and crystal and molecular structure J. Agric. Food Chem. 52 2004 7279 7285
48. J.-G. Fang, M. Lu, Z.-H. Chen, H.-H. Zhu, Y. Li, L. Yang, L.-M. Wu, and Z.-L. Liu Antioxidant effects of resveratrol and its analogues against the free-radical-induced peroxidation of linoleic acid in micelles Chem. Eur. J. 8 2002 4191 4198
49. S. Stojanović, and O. Brede Elementary reactions of the antioxidant action of trans-stilbene derivatives: resveratrol, pinosylvin and 4-hydroxystilbene Phys. Chem. Chem. Phys. 4 2002 757 764
50. L.A. Stivala, M. Savio, F. Carafoli, P. Perucca, L. Bianchi, G. Maga, L. Forti, U.M. Pagnoni, A. Albini, E. Prosperi, and V. Vannini Specific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrol J. Biol. Chem. 276 2001 22586 22594
51. S. Stojanović, H. Sprinz, and O. Brede Efficiency and mechanism of the antioxidant action of trans-resveratrol and its analogues in the radical liposome oxidation Arch. Biochem. Biophys. 391 2001 79 89 (Pubitemid 32612575)
52. M. Wang, Y. Jin, and C.-T. Ho Evaluation of resveratrol derivatives as potential antioxidants and identification of a reaction product of resveratrol and 2,2-diphenyl-1-picryhydrazyl radical J. Agric. Food Chem. 47 1999 3974 3977 (Pubitemid 29506186)
53. D. Mikulski, R. Górniak, and M. Molski A theoretical study of the structure-radical scavenging activity of trans-resveratrol analogues and cis-resveratrol in gas phase and water environment Eur. J. Med. Chem. 45 2010 1015 1027
54. Y.-J. Shang, Y.-P. Qian, X.-D. Liu, F. Dai, X.-L. Shang, W.-Q. Jia, Q. Liu, J.-G. Fang, and B. Zhou Radical-scavenging activity and mechanism of resveratrol-oriented analogues: influence of the solvent, radical, and substitution J. Org. Chem. 74 2009 5025 5031
55. J.-G. Fang, and B. Zhou Structure-activity relationship and mechanism of the tocopherol-regenerating activity of resveratrol and its analogues J. Agric. Food Chem. 56 2008 11458 11463
56. L.-F. Zheng, Q.-Y. Wei, Y.-J. Cai, J.-G. Fang, B. Zhou, L. Yang, and Z.-L. Liu DNA damage induced by resveratrol and its synthetic analogues in the presence of Cu(II) ions: mechanism and structure-activity relationship Free Radic. Biol. Med. 41 2006 1807 1816 (Pubitemid 44839142)
57. G.-J. Fan, X.-D. Liu, Y.-P. Qian, Y.-J. Shang, X.-Z. Li, F. Dai, J.-G. Fang, X.-L. Jin, and B. Zhou 4,4′-Dihydroxy-trans-stilbene, a resveratrol analogue, exhibited enhanced antioxidant activity and cytotoxicity Bioorg. Med. Chem. 17 2009 2360 2365
58. J. Yang, G.-Y. Liu, D.-L. Lu, F. Dai, Y.-P. Qian, X.-L. Jin, and B. Zhou Hybrid-increased radical-scavenging activity of resveratrol derivatives by incorporating a chroman moiety of vitamin E Chem. Eur. J. 16 2010 12808 12813
59. G. Skretas, A.K. Meligova, C. Villalonga-Barber, D.J. Mitsiou, M.N. Alexis, M. Micha-Screttas, B.R. Steele, C.G. Screttas, and D.W. Wood Engineered chimeric enzymes as tools for drug discovery: generating reliable bacterial screens for the detection, discovery, and assessment of estrogen receptor modulators J. Am. Chem. Soc. 129 2007 8443 8457 (Pubitemid 47066506)
60. C. Villalonga-Barber, A.K. Meligova, X. Alexi, B.R. Steele, C.E. Kouzinos, C.G. Screttas, E.S. Katsanou, M. Micha-Screttas, and M.N. Alexis New hydroxystilbenoid derivatives endowed with neuroprotective activity and devoid of interference with estrogen and aryl hydrocarbon receptor-mediated transcription Bioorg. Med. Chem. 19 2011 339 351
61. Z.-P. Zhuang, M.-P. Kung, and H.F. Kung Synthesis of biphenyltrienes as probes for-amyloid plaques J. Med. Chem. 49 2006 2841 2844
62. J.D. Routier, C. Mazière, F.R. Robert, M. Auclair, R. Santus, and J.C. Mazière Diphenylhexatriene as a fluorescent probe for monitoring low density lipoprotein peroxidation Free Radic. Res. 23 1995 301 315
63. T. Mitsudo, W. Fischetti, and R.F. Heck Palladium-catalyzed syntheses of aryl polyenes J. Org. Chem. 49 1984 1640 1646
64. I.F. Benzie, and J.J. Strain The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay Anal. Biochem. 239 1996 70 76
65. S.-L. Deng, W.-F. Chen, B. Zhou, L. Yang, and Z.-L. Liu Protective effects of curcumin and its analogues against free radical-induced oxidative haemolysis of human red blood cells Food Chem. 98 2006 112 119
66. R.F. Hussain, A.M. Nouri, and R.T. Oliver A new approach for measurement of cytotoxicity using colorimetric assay J. Immunol. Meth. 160 1993 89 96
67. A. Krishan Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining J. Cell Biol. 66 1975 188 193
68. F.A. Oberhammer, M. Pavelka, S. Sharma, R. Tiefenbacher, A.F. Purchio, W. Bursch, and R. Schulte-Hermann Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1 Proc. Natl. Acad. Sci. USA 89 1992 5408 5412
69. H. Lecoeur, M.-C. Prévost, and M.-L. Gougeon Oncosis is associated with exposure of phosphatidylserine residues on the outside layer of the plasma membrane: a reconsideration of the specificity of the annexin V/propidium iodide assay Cytometry 44 2001 65 72 (Pubitemid 32434004)
70. A. Watanabe, N. Noguchi, A. Fujisawa, T. Kodama, K. Tamura, O. Cynshi, and E. Niki Stability and reactivity of aryloxyl radicals derived from a novel antioxidant BO-653 and related compounds: effects of substituent and side chain in solution and membranes J. Am. Chem. Soc. 122 2000 5438 5442 (Pubitemid 30431060)
71. J.D. Morrow, K.E. Hill, R.F. Burk, T.M. Nammour, K.F. Badr, and L.J. Roberts III A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism Proc. Natl. Acad. Sci. USA 87 1990 9383 9387 (Pubitemid 120030630)
72. H. Esterbauer, and P. Ramos Chemistry and pathophysiology of oxidation of LDL Rev. Physiol. Biochem. Pharmacol. 127 1995 31 64
73. L.R.C. Barclay Model biomembranes: quantitative studies of peroxidation, antioxidant action, partitioning, and oxidative stress Can. J. Chem. 71 1993 1 16 (Pubitemid 23130396)
74. J.S. Wright, E.R. Johnson, and G.A. DiLabio Predicting the activity of phenolic antioxidants: theoretical method, analysis of substituent effects, and application to major families of antioxidants J. Am. Chem. Soc. 123 2001 1173 1183 (Pubitemid 32148182)
75. W.A. Pryor, T. Strickland, and D.F. Church Comparison of the efficiencies of several natural and synthetic antioxidants in aqueous SDS [sodium dodecyl sulfate] micelle solutions J. Am. Chem. Soc. 110 1988 2224 2229 (Pubitemid 18095726)
76. L. Castle, and M.J. Perkins Inhibition kinetics of chain-breaking phenolic antioxidants in SDS micelles: evidence that intermicellar diffusion rates may be rate-limiting for hydrophobic inhibitors such as α-tocopherol J. Am. Chem. Soc. 108 1986 6381 6382
77. C.D. Selassie, S. Kapur, R.P. Verma, and M. Rosario Cellular apoptosis and cytotoxicity of phenolic compounds: a quantitative structure-activity relationship study J. Med. Chem. 48 2005 7234 7242 (Pubitemid 41743637)
78. C. Hansch, and A. Leo Exploring QSAR: Fundamentals and Applications in Chemistry and Biology 1995 Am. Chem. Soc Washington, DC
79. D. Colin, A. Gimazane, G. Lizard, J.-C. Izard, E. Solary, N. Latruffe, and D. Delmas Effects of resveratrol analogs on cell cycle progression, cell cycle associated proteins and 5-fluoro-uracil sensitivity in human derived colon cancer cells Int. J. Cancer 124 2009 2780 2788
80. U. Stervbo, O. Vang, and C. Bonnesen Time- and concentration-dependent effects of resveratrol in HL-60 and HepG2 cells Cell Prolif. 39 2006 479 493 (Pubitemid 44760200)
81. A. Tyagi, R.P. Singh, C. Agarwal, S. Siriwardana, R.A. Sclafani, and R. Agarwal Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR-Chk1/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells Carcinogenesis 26 2005 1978 1987 (Pubitemid 41631273)
82. Z. Estrov, S. Shishodia, S. Faderl, D. Harris, Q. Van, H.M. Kantarjian, M. Talpaz, and B.B. Aggarwal Resveratrol blocks interleukin-1β-induced activation of the nuclear transcription factor NF-κB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells Blood 102 2003 987 995 (Pubitemid 36917794)
83. A.K. Joe, H. Liu, M. Suzui, M.E. Vural, D. Xiao, and I.B. Weinstein Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines Clin. Cancer Res. 8 2002 893 903 (Pubitemid 34742123)
84. D. Bernhard, I. Tinhofer, M. Tonko, H. Hübl, M.J. Ausserlechner, R. Greil, R. Kofler, and A. Csordas Resveratrol causes arrest in the S-phase prior to Fas-independent apoptosis in CEM-C7H2 acute leukemia cells Cell Death Differ. 7 2000 834 842